Search Results

vehicle by which Andrew is translating fundamental findings to commercial products is Keltic Pharma Therapeutics

record as a biologics leader as he led teams to discover and develop novel first-in-class antibody therapeutics

orphan GPCRs from ‘locked’, inaccessible receptors to well-characterized and understood ‘unlocked’ therapeutic

clinical stage company developing next generation immunotherapies, and member of the SAB of Domain Therapeutics

The ultimate goal of Adriano’s research is to target novel aspects of GPCR signaling for therapeutic

Institute of Medical Research, Deputy Director of the Australian Research Council Centre for Personalised Therapeutics

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics

nanobodies as research tools, to investigate different GPCR conformations, while also focusing on their therapeutic

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

Brian Collier in the Department of Pharmacology and Therapeutics at McGill University (1994).

protein-coupled receptors (GPCRs) regulate motivated behavior and how these receptors can be targeted for therapeutic distinct signaling pathways with their physiological effects and may serve as the basis for more selective therapeutics

Michael Feigin is an Associate Professor in the Department of Pharmacology and Therapeutics, and Director of Graduate Studies of Experimental Therapeutics at Roswell Park Comprehensive Cancer Center in Buffalo disrupting histone processing on rapidly proliferating cells, such as cancer cells, and suggested a therapeutic

receptors would be a significant breakthrough in cardiovascular biology as they could be targeted for therapeutic

Yamina will schedule a future talk with Jacek about GPCRs as therapeutic modalities. The discussion revealed their interest in GPCRs as therapeutic modalities and possible future collaborations

What makes each drug type unique to therapeutic pharmacology? 3.

Celtarys’ cutting-edge fluorescent ligand technology and accelerate the development of GPCR-targeted therapeutics accelerate the adoption of our chemical tools and foster collaborations that turn receptor biology into therapeutic

neuronal circuits — insights that inform next-generation functional assay development and translational therapeutic

of Canada (2014), the Julie Axelrod award from the American Society of Pharmacology and Exerimental Therapeutics

GMT+0000 (Coordinated Universal Time) Details GPCR fragment-based drug discovery enabled by the Confo Therapeutics 2022 15:00:00 GMT+0000 (Coordinated Universal Time) Details Enabling the discovery of next generation therapeutics

understanding the molecular basis for human tumor development and how to use this knowledge to devise new therapeutics Van Meir has developed novel therapeutic approaches for cancer using oncolytic adenoviruses and anti-angiogenic

GPCRs in the regulation of physiologic/pathologic function in the heart in an effort to uncover novel therapeutic

Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic

Award and the Goodman and Gilman Award from the American Society for Pharmacology and Experimental Therapeutics Institute, highlighting its translational approach to research and its capacity to translate research into therapeutic

How target depletion and replenishment kinetics define the therapeutic window.

Departments of Psychiatry and Molecular Pharmacology and Therapeutics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, USA; Division of Molecular Therapeutics, New York State

lesson: Target depletion vs. replenishment dynamics — how offset rates control exposure windows, shape therapeutic

This is the kind of advance that matters for anyone building tools, assays, or therapeutics around receptor

By integrating advanced tools and translational biology, his work directly informs therapeutic strategies

Sep 20, 2022 — First contributor article published: Therapeutic validation of an orphan G protein‐coupled

This is the kind of advance that matters for anyone building tools, assays, or therapeutics around receptor translational impact — giving us new ways to think about receptor pharmacology, biased agonism, and therapeutic lesson: Target depletion vs. replenishment dynamics — how offset rates control exposure windows, shape therapeutic The result: inconsistent exposure, patchy activity, and sometimes, outright therapeutic failure.